Get the Stockscreener App
866.64
0.31%
-2.72
After Hours:
866.64
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Mckesson Corp stock is traded at $866.64, with a volume of 450.55K.
It is down -0.31% in the last 24 hours and down -4.25% over the past month.
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
See More
Previous Close:
$869.36
Open:
$865
24h Volume:
450.55K
Relative Volume:
0.47
Market Cap:
$101.04B
Revenue:
$403.43B
Net Income/Loss:
$5.10B
P/E Ratio:
22.53
EPS:
38.4657
Net Cash Flow:
$5.41B
1W Performance:
-0.92%
1M Performance:
-4.25%
6M Performance:
-1.49%
1Y Performance:
+17.67%
1-Day Range:
$858.76
$871.00
1-Week Range:
$858.76
$907.07
52-Week Range:
$723.68
$999.00
Mckesson Corp Stock (MCK) Company Profile
Name
Mckesson Corp
Sector
Industry
Phone
972-446-4800
Address
6555 STATE HIGHWAY 161, IRVING, TX
Compare MCK vs COR, CAH, HSIC, AHG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MCK
Mckesson Corp
|
866.64 | 101.04B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
306.92 | 58.57B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
220.22 | 50.99B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
86.37 | 9.63B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
0.75 | 642.53M | 14.85M | -136.07M | 7.25M | -0.4726 |
Mckesson Corp Stock (MCK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Overweight |
| Dec-04-24 | Resumed | Mizuho | Neutral |
| Nov-07-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-24-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-05-24 | Reiterated | Leerink Partners | Outperform |
| Aug-08-24 | Reiterated | Mizuho | Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-14-23 | Initiated | Wells Fargo | Equal Weight |
| Mar-31-23 | Initiated | Citigroup | Buy |
| Aug-22-22 | Resumed | Morgan Stanley | Overweight |
| Jul-06-22 | Downgrade | Argus | Buy → Hold |
| Jun-07-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Feb-04-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-07-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Nov-02-21 | Reiterated | Barclays | Overweight |
| Nov-02-21 | Reiterated | BofA Securities | Buy |
| Nov-02-21 | Reiterated | Evercore ISI | Outperform |
| Nov-02-21 | Reiterated | Jefferies | Buy |
| Mar-30-21 | Upgrade | Argus | Hold → Buy |
| Nov-02-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-04-20 | Upgrade | Deutsche Bank | Hold → Buy |
| May-22-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| May-15-20 | Upgrade | UBS | Neutral → Buy |
| Apr-23-20 | Resumed | Credit Suisse | Neutral |
| Mar-18-20 | Upgrade | Goldman | Neutral → Buy |
| Mar-13-20 | Upgrade | Guggenheim | Neutral → Buy |
| Feb-07-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jan-10-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Aug-05-19 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jul-22-19 | Initiated | Guggenheim | Neutral |
| Jan-17-19 | Initiated | UBS | Neutral |
| Oct-26-18 | Reiterated | Barclays | Equal Weight |
| Jul-20-18 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-29-18 | Reiterated | Leerink Partners | Mkt Perform |
| Mar-08-18 | Initiated | Barclays | Equal Weight |
| Feb-27-18 | Resumed | BofA/Merrill | Buy |
| Feb-02-18 | Reiterated | Mizuho | Neutral |
| Jan-24-18 | Upgrade | Jefferies | Hold → Buy |
View All
Mckesson Corp Stock (MCK) Latest News
MCK.GL Bond Profile: Coupon and Redemption - TradingView
Mckesson Stock Price Forecast. Should You Buy MCK? - StockInvest.us
McKesson (MCK) Stock Forecast and Price Target 2026 $MCK - MarketBeat
McKesson Corp. stock underperforms Thursday when compared to competitors - MarketWatch
McKesson raises quarterly dividend by 15% to $0.94 per share - scanx.trade
McKesson ideaShare 2026 fuels momentum for independent pharmacies - scanx.trade
TD Cowen maintains Buy on McKesson, cuts price target to $989 - scanx.trade
McKesson 5-year return hits 34.23%, beating market by 22.21% - scanx.trade
Here’s How Much You Would Have Made Owning McKesson Stock In The Last 5 Years - Benzinga
Cardinal Health vs. McKesson: Which Healthcare Stock Is Better? - Yahoo Finance
Why McKesson (MCK) Dipped More Than Broader Market Today - Yahoo Finance
McKesson Corp. stock outperforms competitors despite losses on the day - MarketWatch
McKesson Corporation Announces Second Quarter Fiscal 2027 Earnings Release Date - Yahoo Finance
McKesson stock heads into the open after a 1.3% gain - AD HOC NEWS
McKesson Corp. stock rises Monday, still underperforms market - MarketWatch
Dig: Precision Medicine Group McKesson ACQ premature (not closed) - Dealroom.co
McKesson stock heads into the open after a 1.5 percent slide - AD HOC NEWS
Why Is McKesson (MCK) a Stock to Watch Today? - Kalkine Media
McKesson Cyberattack: Stolen Data Includes 6.4 Million Unique Email Addresses - The HIPAA Journal
6.4 Million Email Addresses Exposed in McKesson Hack - BankInfoSecurity
Mckesson Corp. (0JZU) Q2 2025 Earnings ReportResults, Call & Slides - TipRanks
Mckesson Corp. (0JZU) Q4 2026 Earnings ReportResults, Call & Slides - TipRanks
McKesson (MCK) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Yahoo Finance
Mckesson Corp. (0JZU) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
McKesson Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
A Look at McKesson Corp (MCK) After 3.3% Gain -- GF Value $829.6 - GuruFocus
McKesson Corp. stock outperforms competitors on strong trading day - MarketWatch
McKesson Raises Outlook, Eyes Oncology Growth With Precision Medicine Deal - Yahoo Finance
Lawsuits Over McKesson Voice-Phishing Attack Points to Ongoing Risk in Healthcare Sector - Law.com
McKesson stock heads into the open after a 1.2% drop - ad-hoc-news.de
McKesson (MCK) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance
McKesson Corp (MCK) Insider Sale: SVP, Controller & CAO Rutledge Napoleon B JR Sells 111 Shares - GuruFocus
McKesson (MCK) Plans A $2.25b Deal, Is The Stock Fully Valued? - simplywall.st
McKesson Senior VP Napoleon Rutledge Jr. Sells 111 Shares via 10b5-1 Trading Plan - Kalkine Media
ShinyHunters expose 6.4M in attack on medical supplier McKesson - The Register
Why Is McKesson (NYSE:MCK) Stock In Focus Today? - Kalkine Media
McKesson (NYSE:MCK): Is the Cyber Risk Overpriced? - Kalkine Media
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
McKesson Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
McKesson Eyes $2.25B Precision Medicine Deal as Oncology Growth Accelerates - Yahoo Finance
McKesson at wells fargo healthcare conference: growth, deal push - investing.com
McKesson Corp's negligence caused a data breach, a new class action lawsuit claims - claimdepot.com
Novocure Reports Patient Data Exposure in Cybersecurity Incident - Zacks Investment Research
McKesson Bets $2.25 Billion More on Oncology With Precision Medicine Buy - Yahoo Finance
McKesson Stock (MCK) Opinions on Recent Data Leak and Market Dynamics - Quiver Quantitative
McKesson Corp Lobbying Profile, 2012 - OpenSecrets
McKesson Owns Antitrust Claims, Not Rite Aid, Judge Finds - law360.com
McKesson Corp. stock underperforms Friday when compared to competitors - MarketWatch
McKesson Corp (MCK) Stock Price, Quote, News & History - Benzinga
McKesson Data Breach: Investigation Ongoing - Claim Depot
Why Is McKesson (MCK) Up 5.7% Since Last Earnings Report? - finance.yahoo.com
Mckesson Corp Stock (MCK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.95%
0.98%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):